《血浆微小RNA-216a/b在食管鳞状细胞癌诊断中的预测价值》勘误
Corrigendum to "Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma".
作者信息
Dong Shuling, Yin Huiqing, Dong Cuicui, Sun Kaiyan, Lv Pin, Meng Weiwei, Ming Liang, He Fucheng
机构信息
Department of Medical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China; Key Medical Laboratory of Henan Province, Zhengzhou, Henan 450052, China.
Department of Medical Laboratory, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
出版信息
Dis Markers. 2017;2017:3437679. doi: 10.1155/2017/3437679. Epub 2017 Mar 12.
Abstract
[This corrects the article DOI: 10.1155/2016/1857067.].
摘要
[本文更正了文章的数字对象标识符：10.1155/2016/1857067。]
相似文献
1
Corrigendum to "Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma".《血浆微小RNA-216a/b在食管鳞状细胞癌诊断中的预测价值》勘误
Dis Markers. 2017;2017:3437679. doi: 10.1155/2017/3437679. Epub 2017 Mar 12.
2
Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.血浆微小RNA-216a/b在食管鳞状细胞癌诊断中的预测价值
Dis Markers. 2016;2016:1857067. doi: 10.1155/2016/1857067. Epub 2016 Feb 18.
3
Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma.勘误：瞬时受体电位通道蛋白1（TRPC1）抑制细胞增殖/侵袭，可预测食管鳞状细胞癌的较好预后。
Front Oncol. 2021 Oct 6;11:767805. doi: 10.3389/fonc.2021.767805. eCollection 2021.
4
Corrigendum to "Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis".《基于基因表达数据和微小RNA-信使核糖核酸网络分析鉴定口腔鳞状细胞癌诊断生物标志物微小RNA》勘误
Comput Math Methods Med. 2017;2017:1284606. doi: 10.1155/2017/1284606. Epub 2017 Dec 28.
5
MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.微小RNA-216a通过靶向真核生物翻译起始因子4B抑制口腔鳞状细胞癌的生长和转移。
Mol Med Rep. 2015 Aug;12(2):3156-62. doi: 10.3892/mmr.2015.3761. Epub 2015 May 8.
6
Corrigendum to "A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma".《用于食管鳞状细胞癌研究的多功能原位裸鼠模型》勘误
Biomed Res Int. 2016;2016:2348673. doi: 10.1155/2016/2348673. Epub 2016 Jul 4.
7
Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma.勘误：安罗替尼联合放化疗在食管鳞状细胞癌中显示出显著的治疗效果。
Front Oncol. 2020 Nov 20;10:583499. doi: 10.3389/fonc.2020.583499. eCollection 2020.
8
MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma.微小RNA-21调控食管鳞状细胞癌的增殖与侵袭。
Clin Cancer Res. 2009 Mar 15;15(6):1915-22. doi: 10.1158/1078-0432.CCR-08-2545. Epub 2009 Mar 10.
9
Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis.勘误：食管鳞状细胞癌脑转移：临床特征与预后
Front Oncol. 2022 Feb 4;12:827810. doi: 10.3389/fonc.2022.827810. eCollection 2022.
10
Erratum: Long Non-Coding RNA CASC2 Serves As A ceRNA Of microRNA-21 To Promote PDCD4 Expression In Oral Squamous Cell Carcinoma [Corrigendum].勘误：长链非编码RNA CASC2作为微小RNA-21的ceRNA促进口腔鳞状细胞癌中PDCD4的表达[勘误]
Onco Targets Ther. 2019 Nov 13;12:9569. doi: 10.2147/OTT.S235046. eCollection 2019.
引用本文的文献
1
microRNA-144 inhibits cell proliferation and invasion by directly targeting TIGAR in esophageal carcinoma.微小RNA-144通过直接靶向食管癌中的TIGAR抑制细胞增殖和侵袭。
Oncol Lett. 2020 Apr;19(4):3079-3088. doi: 10.3892/ol.2020.11420. Epub 2020 Feb 24.
本文引用的文献
1
Predictive Value of Plasma MicroRNA-216a/b in the Diagnosis of Esophageal Squamous Cell Carcinoma.血浆微小RNA-216a/b在食管鳞状细胞癌诊断中的预测价值
Dis Markers. 2016;2016:1857067. doi: 10.1155/2016/1857067. Epub 2016 Feb 18.
Zotero 插件